Mehmet Asim Bilen
Overview
Explore the profile of Mehmet Asim Bilen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
1792
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhuang T, Goyal S, Case K, Olsen T, Vemuru S, Yildirim A, et al.
J Immunother Precis Oncol
. 2025 Jan;
8(1):1-10.
PMID: 39811423
Introduction: Advanced penile squamous cell carcinoma (pSCC) is a rare and aggressive malignancy with a poor prognosis and an unmet need for biomarkers. We performed a retrospective evaluation of real-world...
2.
Case K, Martini D, Dababneh M, Bidot S, Nazha B, Brown J, et al.
Am J Clin Pathol
. 2024 Dec;
PMID: 39705501
Objectives: Urothelial carcinomas (UCs) encompass a heterogeneous group of tumors. Several histopathologic features are associated with poor clinical outcomes and limited treatment options. With new rising therapeutic modalities, we aimed...
3.
Cardenas M, Prokhnevska N, Sobierajska E, Gregorova P, Medina C, Valanparambil R, et al.
Nature
. 2024 Nov;
635(8039):E9.
PMID: 39506126
No abstract available.
4.
Cardenas M, Prokhnevska N, Sobierajska E, Gregorova P, Medina C, Valanparambil R, et al.
Nature
. 2024 Oct;
636(8041):224-232.
PMID: 39443797
The T cell response to cancer controls disease progression and response to immunotherapy. Despite extensive knowledge regarding CD8 T cells, how CD4 T cells contribute to this process is less...
5.
Apolo A, Ballman K, Sonpavde G, Berg S, Kim W, Parikh R, et al.
N Engl J Med
. 2024 Sep;
392(1):45-55.
PMID: 39282902
Background: Muscle-invasive urothelial carcinoma is an aggressive disease with high rates of relapse. Whether pembrolizumab as adjuvant therapy would be effective in patients with high-risk muscle-invasive urothelial carcinoma after radical...
6.
Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race
Bilen M, Khilfeh I, Rossi C, Muser E, Morrison L, Hilts A, et al.
Clinicoecon Outcomes Res
. 2024 Sep;
16:657-674.
PMID: 39257456
Background: Alterations in DNA damage repair genes in advanced prostate cancer (PC) may impact responses to therapy and clinical outcomes. This study described homologous recombination repair (HRR) testing patterns and...
7.
Broderick A, Pan E, Li J, Chu A, Hwang C, Barata P, et al.
Prostate Cancer Prostatic Dis
. 2024 Jul;
PMID: 39019980
Background: Aberrant Wnt signaling has been implicated in prostate cancer tumorigenesis and metastasis in preclinical models but the impact of genetic alterations in Wnt signaling genes in men with advanced...
8.
Gulati S, Barata P, Elliott A, Bilen M, Burgess E, Choueiri T, et al.
J Clin Invest
. 2024 Jul;
134(14).
PMID: 39007269
BACKGROUNDMetastases are the hallmark of lethal cancer, though underlying mechanisms that drive metastatic spread to specific organs remain poorly understood. Renal cell carcinoma (RCC) is known to have distinct sites...
9.
Martini D, Case K, Gratz D, Pellegrini K, Beagle E, Schneider T, et al.
Cancer
. 2024 Jul;
130(21):3658-3670.
PMID: 38959291
Background: Bladder cancer with divergent differentiation (BCDD) comprises a heterogenous group of tumors with a poor prognosis, and differential expression of nectin-4 and programmed death ligand-1 (PD-L1) has been reported...
10.
Goswamy R, Kalemoglu E, Master V, Bilen M
Front Oncol
. 2024 Jun;
14:1362172.
PMID: 38841158
In this review, we aim to provide a comprehensive assessment of the evolving landscape of the perioperative management in renal cell carcinoma (RCC), emphasizing its dynamic and intricate nature. We...